发明申请
WO2005082346A1 USE OF CYSTEINYL LEUKOTRIENE 2 RECEPTOR ANTAGONISTS
审中-公开
CYSTEINYL LEUKOTRIENE 2受体拮抗剂的使用
- 专利标题： USE OF CYSTEINYL LEUKOTRIENE 2 RECEPTOR ANTAGONISTS
- 专利标题（中）： CYSTEINYL LEUKOTRIENE 2受体拮抗剂的使用
-
申请号： PCT/US2005/005683申请日： 2005-02-24
-
公开(公告)号： WO2005082346A1公开(公告)日： 2005-09-09
- 发明人: EVANS, Jilly , FORD-HUTCHINSON, Anthony , HUTCHINSON, John, H. , YOUNG, Robert
- 申请人： MERCK & CO., INC. , MERCK FROSST CANADA & CO. , EVANS, Jilly , FORD-HUTCHINSON, Anthony , HUTCHINSON, John, H. , YOUNG, Robert
- 申请人地址： 126 East Lincoln Avenue, Rahway, New Jersey 07065-0907 US
- 专利权人： MERCK & CO., INC.,MERCK FROSST CANADA & CO.,EVANS, Jilly,FORD-HUTCHINSON, Anthony,HUTCHINSON, John, H.,YOUNG, Robert
- 当前专利权人： MERCK & CO., INC.,MERCK FROSST CANADA & CO.,EVANS, Jilly,FORD-HUTCHINSON, Anthony,HUTCHINSON, John, H.,YOUNG, Robert
- 当前专利权人地址： 126 East Lincoln Avenue, Rahway, New Jersey 07065-0907 US
- 代理机构： MERCK & CO., INC.
- 优先权： US60/547,876 200402026; US60/633,113 20041203
- 主分类号： A61K31/16
- IPC分类号： A61K31/16
摘要：
The instant invention provides a method for treating and/or reducing the risk for atherosclerosis, pulmonary fibrosis and stroke, comprising administering an effective amount of a cysteinyl leukotriene 2 receptor antagonist, including a selective cysteinyl leukotriene 2 receptor antagonist and a dual cysteinyl leukotriene 1 receptor and cysteinyl leukotriene 2 receptor antagonist to a patient in need of such treatment.
